Form 4: Director Celeste Granted 250,000 Range Impact Stock Options

Sentiment:

Insider Transaction Report


Range Impact Director Richard F. Celeste was granted 250,000 stock options with an exercise price of $0.15, vesting immediately.

Summary

  • Richard F. Celeste, a Director of RANGE IMPACT, INC. (RNGE), was granted stock options.
  • The grant occurred on December 31, 2025.
  • The options allow the purchase of 250,000 shares of common stock.
  • The exercise price for these options is $0.15 per share.
  • The options vested immediately upon grant.
  • The options expire on December 31, 2035.
  • Following this transaction, Richard F. Celeste beneficially owns 1,750,000 derivative securities (stock options).

Sentiment

Score: 6

Explanation: The grant of stock options to a director is generally viewed as a positive for corporate governance and alignment of interests, though it doesn't reflect immediate operational or financial performance.

Positives

  • The grant of 250,000 stock options to Director Richard F. Celeste aligns his interests with those of shareholders, incentivizing long-term company performance.
  • The immediate vesting of the options provides immediate equity exposure and potential upside for the director.

Negatives

  • The exercise of these options in the future could lead to a dilution of existing shareholder equity.

Risks

  • The value of the stock options is dependent on the future market price of RANGE IMPACT, INC. common stock exceeding the $0.15 exercise price.
  • If the company's stock price does not perform well, the options may expire worthless.

Future Outlook

The grant of stock options indicates an expectation of future value creation for RANGE IMPACT, INC., as the options only become profitable if the stock price rises above the exercise price of $0.15.

Industry Context

Stock option grants are a common form of executive and director compensation in publicly traded companies, used to align the interests of management and directors with those of shareholders by providing an incentive for long-term stock price appreciation.

Comparison to Industry Standards

  • Granting stock options with an exercise price is a standard practice for compensating directors and executives across various industries, including technology and manufacturing, to incentivize performance.
  • The immediate vesting of options, while not universal, is also seen in some compensation structures, particularly for directors, to provide immediate alignment.
  • The 10-year expiration period (12/31/2025 to 12/31/2035) is a typical duration for employee and director stock options.

Stakeholder Impact

  • Shareholders: Potential for future dilution if options are exercised, but also benefits from increased director alignment and incentive for stock price growth.
  • Director (Richard F. Celeste): Receives a significant equity incentive, aligning his personal financial interests with the long-term success of the company.

Next Steps

  • Richard F. Celeste may choose to exercise these options at any time between the grant date and the expiration date, provided the stock price is favorable.

Key Dates

DateDescription
01/07/2025Signature date of the reporting person on the Form 4.
12/31/2025Date of earliest transaction, when 250,000 stock options were granted and vested immediately.
12/31/2035Expiration date of the granted stock options.

Keywords

Range Impact, RNGE, Richard F. Celeste, stock options, insider transaction, Form 4, director compensation, equity grant, beneficial ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.